ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,212.80
-0.48%
Dow Jones
40,421.36
0.33%
Brent Oil
81.705
0.23%
Bitcoin
66,862.05
-1.10%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Ovoca Bio Plc (OVB) Quote

Ovoca Bio Plc

Ovoca Bio Plc (OVB)

Overlay Shares Core Bond ETF
1.075
0.00
( 0.00% )
Updated: 03:00:03
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.075
Bid
1.00
Ask
1.15
Volume
0.00
0.975 Day's Range 1.075
0.55 52 Week Range 14.25
Market Cap
876.811k
Previous Close
1.075
Open
0.975
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
624,573
Shares Outstanding
81,563,806
Dividend Yield
-
PE Ratio
-0.19
Earnings Per Share (EPS)
-0.06
Revenue
1.75M
Net Profit
-4.7M

About Ovoca Bio Plc

Sector
Pharmaceutical Preparations
Industry
Metal Mining Services
Website
www.ovocabio.com
Headquarters
Dublin, Irl
Founded
2018
Ovoca Bio Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker OVB. The last closing price for Ovoca Bio was 1.08p. Over the last year, Ovoca Bio shares have traded in a share price range of 0.55p to 14.25p.

Ovoca Bio currently has 81,563,806 shares outstanding. The market capitalization of Ovoca Bio is £876,810.91 . Ovoca Bio has a price to earnings ratio (PE ratio) of -0.19.

OVB Latest News

More News

DIRECTOR DEALINGS: Jet2 chair buys; Ovoca Bio's old CEO sells to new

The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and ...

July 15 2024
Alliance News

Ovoca Bio PLC Directorate Change

Ovoca Bio PLC 15 July 2024     Ovoca Bio PLC 15 July 2024   This announcement contains inside information   Ovoca Bio plc   ("Ovoca" or the "Company")   Ovoca Bio Announces Management Change  ...

July 15 2024
RNS Regulatory News

Ovoca Bio PLC Director/PDMR Shareholding

Ovoca Bio PLC 15 July 2024   Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them    This form is required for disclosure of...

July 15 2024
RNS Regulatory News

EARNINGS: AssetCo proposes name change; i(x) Net Zero eyes AIM exit

The following is a round-up of earnings for London-listed companies, issued last week and not separately reported by ...

July 03 2024
Alliance News

Ovoca Bio PLC Annual Financial Report

Ovoca Bio PLC 28 June 2024   Ovoca Bio plc   ("Ovoca" or the "Company")     Publication of 2023 Annual Report   Dublin, Ireland, June 28, 2024  - Ovoca Bio, a biopharmaceutical company with a...

June 28 2024
RNS Regulatory News

Ovoca Bio PLC Holding(s) in Company

Ovoca Bio PLC 23 January 2024 Ovoca Bio plc ("Ovoca" or the "Company") Holding(s) in Company Dublin, Ireland, January 23, 2024 - Ovoca Bio, a biopharmaceutical company with a...

January 23 2024
UK Regulatory

Ovoca Bio PLC Result of AGM

Ovoca Bio PLC 01 December 2023 Ovoca Bio plc ("Ovoca" or the "Company") Result of AGM Dublin, Ireland, December 1, 2023 - Ovoca Bio, a biopharmaceutical company with a focus...

December 01 2023
UK Regulatory

Ovoca Bio PLC Notice of AGM

Ovoca Bio PLC 07 November 2023 Ovoca Bio plc ("Ovoca" or the "Company") Notice of AGM Dublin, Ireland, November 7 , 2023 - Ovoca Bio, a biopharmaceutical company with a focus...

November 07 2023
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.025-2.272727272731.11.250.97510103471.13591125DE
40.1516.21621621620.9251.250.757683771.02016312DE
120.2530.3030303030.8251.3250.7256245730.96354589DE
260.22526.47058823530.851.3250.554104490.91147508DE
52-7.425-87.35294117658.514.250.554061542.06188449DE
156-9.175-89.51219512210.2525.50.551948754.93075554DE
260-9.425-89.761904761910.5290.551815888.17484276DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NMHINatures Miracle Holding Inc
$ 0.9602
(174.34%)
4.06M
LGHLWLion Group Holding Ltd
$ 0.0093
(30.99%)
156
FEIMFrequency Electronics Inc
$ 13.17
(30.40%)
18.47k
ENGENGlobal Corp
$ 2.22
(29.82%)
258
TUSKMammoth Energy Services Inc
$ 4.33
(23.71%)
22.93k
RNAZTransCode Therapeutics Inc
$ 0.3346
(-57.78%)
220.99k
MIRAMIRA Pharmaceuticals Inc
$ 3.44
(-31.34%)
469.08k
NUKKNukkleus Inc
$ 0.3946
(-20.76%)
59.19k
XCURExicure Inc
$ 0.4119
(-17.59%)
3.44k
CMAXCareMax Inc
$ 4.52
(-12.91%)
100.66k
NMHINatures Miracle Holding Inc
$ 0.9602
(174.34%)
4.06M
BREABrera Holdings PLC
$ 0.73
(-0.96%)
1.44M
LIFWMSP Recovery Inc
$ 0.6244
(23.23%)
1.42M
SLNASelina Hospitality PLC
$ 0.0348
(-5.95%)
613.82k
SERVServe Robotics Inc
$ 8.42
(-3.99%)
594.39k

Discussion

View Full Feed
B_B! B_B! 9 minutes ago
AMC has restructured its debt, I hope Amazon will make a move soon.
Amazon is still expanding its film business.

Amazon Prime Video acquires the iconic Bray Film Studios in the UK
July 22, 2024

The legendary Bray Film Studios will be the new production ho
AMC
stock1ace1 stock1ace1 12 minutes ago
Brea .74
Tom turtles Tom turtles 13 minutes ago
This is one crazy stock
SYTA
Monksdream Monksdream 13 minutes ago
Bloomberg reported that $81 million, a one-day record amount was raised for the Democrats
Certainly an expression of confidence in Harris
ShadowDiviner72 ShadowDiviner72 16 minutes ago
Finally, we arrived to the day we have been waiting for since November 2023. I want to highlight 1 fact:
"Since all patient data will be included in the final locked database, we will remain blinded and will announce the comprehensive results of the full trial, including Stage II results, ra
JAGX
Bull_Dolphin Bull_Dolphin 18 minutes ago
More on the narrative unravelling:

https://revolver.news/2024/07/entire-trump-assassination-plot-about-to-blow-thanks-to-mysterious-atf-agent-just-went-dark/
stock1ace1 stock1ace1 18 minutes ago
Brea .69
ddls ddls 18 minutes ago
Looks like you're still PRETENDING.
BIEL
Here Today Here Today 19 minutes ago
“The Company intends to use the net proceeds from the offering primarily for product development activities, including one or more clinical trials with TTX-MC138, its lead therapeutic candidate, and related investigational new drug (IND) enabling studies, and for working capital and other general co
RNAZ
Here Today Here Today 20 minutes ago
Just sucks that they priced the offering at $.30 a share for 10 million shares. They need the trial to start ASAP.
RNAZ
LVerstee LVerstee 21 minutes ago
To clarify your statement:

According to your message, the current selling price is $8.88 per TOKEN, while the buyback price is only $4.93. This results in a substantial spread of $3.95 per TOKEN, favoring the company.

This significant discrepancy suggests that the TOKEN
ITUP
Here Today Here Today 22 minutes ago
Time to munch on the cheapies!!!!
RNAZ
glenn1919 glenn1919 25 minutes ago
TC.....................................https://stockcharts.com/h-sc/ui?s=TC&p=W&b=5&g=0&id=p84354014936
gregcod gregcod 25 minutes ago
Doing the same thing over and over again, and expecting different results is Einsteins definition of insanity...Coal and fossil fuels have been are destroying the earths environment for far long...Impacting the oceans and atmosphere plus the billions of people who inhabit the earth in disaterous wa
IBATF
Here Today Here Today 26 minutes ago
Way oversold for a $3million offering.

https://www.think-equity.com/transactions
RNAZ
Bull_Dolphin Bull_Dolphin 28 minutes ago
Hey getmore, I thought the video you posted would get squashed and disappear, but low and behold that great patriot Senator Ron Johnson has brought it forward:

https://www.wnd.com/2024/07/watch-u-s-senator-video-shows-at-least-three-different-weapons-fired-during-trump-shooting/
pennyonfire pennyonfire 30 minutes ago
$RLTR .012 PINK Current.
RLTR
glenn1919 glenn1919 34 minutes ago
SOAR..................................https://stockcharts.com/h-sc/ui?s=SOAR&p=W&b=5&g=0&id=p84354014936
ramalio ramalio 37 minutes ago
... and several hate-tirades from always the same obvious self-described "experts" ... LOL.
BMXI
archilles archilles 37 minutes ago
Did anyone ask the RSPI ceo when we expect to come out of EM?
Was it intentional or unintentional for RSPI to get to be in the EM status?
Are they redoing the filing with a brand new audit?
RSPI
chicks0123 chicks0123 39 minutes ago
Good morning CLNVERS
CLNV
GMH* GMH* 46 minutes ago
The main reason I think that it is a biotech portfolio shorting approach is that 1) when short HFs create a company specific short thesis, they generally build a big short position and then publish a white paper on "best short of the year" and then cover on the subsequent drop, whereas the current a
IOVA
Handlamera Handlamera 47 minutes ago
Ok! Thank you for this explanation!
So on Friday when trading starts we will have an order book looking like,this.

Buy Sell
4,90 8,90

This backed by the company.

Then the market will decide the actual real m
ITUP
kabunushi kabunushi 48 minutes ago
"when set aside funds run low" Doc, could you please clarify what you mean by this? I know there are some UK cancer charity funds in the UK , like CDF (Cancer drug fund) and Cancer Research UK. Are either of those the source of funds patients can apply to in order to get the cost of DcVax paid for
NWBO

Your Recent History

LSE
OVB
Ovoca Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved